Bluesky · Hashtag

#uti

88
posts · 30d
16
users
3
posts / day
5.5
posts / user
+ 33% vs last week

#uti is an active hashtag on Bluesky. In the last 30 days, 16 people shared 88 posts with it — around 3 a day. Activity is up 33% versus the previous week, peaking on Jul 24 with 7 posts.

#uti posts per day (last 30 days)

Posts with #uti

Carmen Aguilar
@carmen-aguilar.bsky.social
7 months ago
Our first paper is out today in @natmicrobiol.nature.com! We introduce a prostate organoid model and show that UPEC invades prostate cells via FimH binding to the prostate-specific protein PAPP. A step toward targeted therapies against bacterial prostatitis. 🎉 #UTI #UPEC #Organoids #AMR
Uropathogenic Escherichia coli invade luminal prostate cells via FimH–PPAP receptor binding - Nature Microbiology

www.nature.com

Uropathogenic Escherichia coli invade luminal prostate cells via FimH–PPAP receptor binding - Nature Microbiology

Uropathogenic Escherichia coli infection of a murine prostate organoid model reveals a bacterial FimH–host prostatic acid phosphatase adhesin-receptor interaction enabling invasion and replication wit...

2 19 35
Scunthorpe United FC
@sufcofficial.bsky.social
over 1 year ago
🔵🌅 𝐁𝐋𝐔𝐄𝐒𝐊𝐘 🤔 Another new social media platform to contend with! ✅ Another avenue to keep up to date with the Iron! 🤝 Follow @SUFCOfficial.bsky.social to keep up to date with our latest platform. #UTI #IRON
4 3 31
CMI Communications
@cmicomms.bsky.social
over 1 year ago
📣 Concise review by Zohar, Yahav et al.: Aminoglycosides having a renaissance for MDRO #UTI infections, esp. when new BL/BLI combinations not available. They're effective & not as toxic at short durations (and all AG are not equal in toxicity!) #IDSky #MedSky #WAAW www.cmi-comms.com/article/S295...
Abstract of the new concise clinical review by Zohar, Yahav et al. on management strategies for MDRO UTI: 
Background
Urinary tract infections (UTI) are common, with increasing rates of multidrug resistant pathogens in some countries. Recent trials suggest efficacy of new beta-lactam beta-lactamase inhibitors compared to carbapenems, piperacillin-tazobactam, or quinolones for UTI; however, these newer drugs, as well as the comparators, should probably be reserved for severe and/or non-urinary infections. Aminoglycosides have broad Gram-negative spectra, achieve high concentrations in the urinary system, and are associated with low collateral damage to microbiota compared to beta-lactams and quinolones.
Objective
To summarize the evidence supporting the use of aminoglycosides as both empirical and definitive therapy for UTI, mainly in areas with high rates of multidrug-resistant Gram-negative organisms.
Source
Published medical literature (Medline via Pubmed).
Content and implications
Recent data show high susceptibility rates of Enterobacterales to amikacin, second only to susceptibility to plazomicin and carbapenems. Accumulating evidence from older randomized controlled trials and recent observational studies demonstrates no difference in mortality or clinical response between aminoglycosides and comparators, while newer data suggest that with proper dosing and monitoring, aminoglycosides are safe. Nephrotoxicity rates, once a main concern with aminoglycosides, have been demonstrated in recent studies to be similar to those of other antibiotics when aminoglycosides are administered once daily. Current international guidelines also recommend aminoglycosides as a treatment option for complicated UTI and pyelonephritis. Additional studies are needed to provide updated data on nephrotoxicity and ototoxicity rates using once daily dosing with/without therapeutic drug monitoring.
4 8 31

Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.